Transvascular delivery of small interfering RNA to the central nervous system

Nature

Volumn 448, Issue 7149, 2007, Pages 39-43

  Kumar, Priti ^a   Wu, Haoquan ^a   McBride, Jodi L ^b   Jung, Kyeong Eun ^c   Hee Kim, Moon ^c   Davidson, Beverly L ^b   Kyung Lee, Sang ^d   Shankar, Premlata ^a   Manjunath, N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Samchully Pharm Co Ltd   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARBON; CHOLINERGIC RECEPTOR; CYTOKINE; PEPTIDE ANTIBODY; SMALL INTERFERING RNA; VIRUS PROTEIN;

ANTIBIOTICS; BRAIN; DISEASE TREATMENT; ENCEPHALITIS; NERVOUS SYSTEM; PEPTIDE; PROTEIN; RNA; RODENT; VIRAL DISEASE;

ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RNA BINDING; VIRUS ENCEPHALITIS;

MUS; RABIES VIRUS;

EID: 34447114618     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05901     Document Type: Article

References (36)

1. de Boer, A. G. & Gaillard, P. J. Drug Targeting to the brain. Annu. Rev. Pharmacol. Toxicol. 47, 323-355 (2007).
2. Miller, G. Drug targeting. Breaking down barriers. Science 297, 1116-1118 (2002).
3. Schlachetzki, F., Zhang, Y., Boado, R. J. & Pardridge, W. M. Gene therapy of the brain: the trans-vascular approach. Neurology 62, 1275-1281 (2004).
4. Lentz, T. L., Burrage, T. G., Smith, A. L., Crick, J. & Tignor, G. H. Is the acetylcholine receptor a rabies virus receptor? Science 215, 182-184 (1982).
5. Lafon, M. Rabies virus receptors. J. Neurovirol. 11, 82-87 (2005).
6. Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401-406 (2003).
7. Mazarakis, N. D. et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109-2121 (2001).
8. Kumar, P., Lee, S. K., Shankar, P. & Manjunath, N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med. 3, e96 (2006).
9. Leonard, S. & Bertrand, D. Neuronal nicotinic receptors: from structure to function. Nicotine Tob. Res. 3, 203-223 (2001).
10. Lentz, T. L. Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J. Mol. Recognit. 3, 82-88 (1990).
11. Notter, M. F. & Leary, J. F. Flow cytometric analysis of tetanus toxin binding to neuroblastoma cells. J. Cell. Physiol. 125, 476-484 (1985).
12. Chen, T. J., Chen, S. S., Wu, R. E., Wang, D. C. & Lin, C. H. Implication of nNOS in the enlargement of AChR aggregates but not the initial aggregate formation in a novel coculture model. Chin. J. Physiol. 48, 129-138 (2005).
13. Gotti, C. & Clementi, F. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 74, 363-396 (2004).
14. Gupta, B., Levchenko, T. S. & Torchilin, V. P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 57, 637-651 (2005).
15. Dietz, G. P. & Bahr, M. Peptide-enhanced cellular internalization of proteins in neuroscience. Brain Res. Bull. 68, 103-114 (2005).
16. Deshayes, S., Morris, M. C., Divita, G. & Heitz, F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 62, 1839-1849 (2005).
17. Wender, P. A. et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97, 13003-13008 (2000).
18. Kim, W. J. et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol. Ther. 14, 343-350 (2006).
19. Hino, T. et al. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells. Biochem. Biophys. Res. Commun. 340, 263-267 (2006).
20. Akaneya, Y., Jiang, B. & Tsumoto, T. RNAi-induced gene silencing by local electroporation in targeting brain region. J. Neurophysiol. 93, 594-602 (2005).
21. Diamond, M. S., Shrestha, B., Marri, A., Mahan, D. & Engle, M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77, 2578-2586 (2003).
22. Neyts, J., Leyssen, P. & De Clercq, E. Infections with flaviviridae. Verh. K. Acad. Geneeskd Belg. 61, 661-697 (1999).
23. Judge, A. D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nature Biotechnol. 23, 457-462 (2005).
24. Hoyer, D. et al. Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disorders. J. Recept. Signal Transduct. Res. 26, 527-547 (2006).
25. Dorn, G. et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32, e49 (2004).
26. Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173-178 (2004).
27. Morrissey, D. V. et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nature Biotechnol. 23, 1002-1007 (2005).
28. Zimmermann, T. S. et al. RNAi-mediated gene silencing in non-human primates. Nature 441, 111-114 (2006).
29. Noble, C. O. et al. Development of ligand-targeted liposomes for cancer therapy. Expert Opin. Ther. Targets 8, 335-353 (2004).
30. Zhang, Y. et al. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin. Cancer Res. 10, 3667-3677 (2004).
31. Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E. & Triche, T. J. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65, 8984-8992 (2005).
32. Juliano, R. L. Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA. Curr. Opin. Mol. Ther. 7, 132-136 (2005).
33. Melikov, K. & Chernomordik, L. V. Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery. Cell. Mol. Life Sci. 62, 2739-2749 (2005).
34. Henriques, S. T., Melo, M. N. & Castanho, M. A. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399, 1-7 (2006).
35. Song, E. et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nature Biotechnol. 23, 709-717 (2005).
36. Schutz, B. et al. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J. Neurosci. 25, 7805-7812 (2005).